Berliner Boersenzeitung - US abortion ruling threatens access to arthritis drug

EUR -
AED 3.827558
AFN 70.343739
ALL 96.964833
AMD 406.16103
ANG 1.879506
AOA 951.933123
ARS 1046.501742
AUD 1.602528
AWG 1.878327
AZN 1.775652
BAM 1.957994
BBD 2.10556
BDT 124.618464
BGN 1.957775
BHD 0.392718
BIF 3016.786406
BMD 1.042068
BND 1.405609
BOB 7.20618
BRL 6.063693
BSD 1.042869
BTN 88.025462
BWP 14.247172
BYN 3.412907
BYR 20424.529726
BZD 2.102106
CAD 1.45641
CDF 2991.777155
CHF 0.931343
CLF 0.037263
CLP 1028.187912
CNY 7.549824
CNH 7.564496
COP 4605.53346
CRC 531.195309
CUC 1.042068
CUP 27.614798
CVE 110.77587
CZK 25.3473
DJF 185.196707
DKK 7.457736
DOP 62.993411
DZD 139.652412
EGP 51.764412
ERN 15.631018
ETB 128.595208
FJD 2.371695
FKP 0.822522
GBP 0.831596
GEL 2.855673
GGP 0.822522
GHS 16.46869
GIP 0.822522
GMD 73.987187
GNF 8994.087925
GTQ 8.050022
GYD 218.177652
HKD 8.112285
HNL 26.264109
HRK 7.43334
HTG 136.893416
HUF 411.752671
IDR 16594.930403
ILS 3.861429
IMP 0.822522
INR 87.996951
IQD 1365.629908
IRR 43863.244665
ISK 145.493914
JEP 0.822522
JMD 166.136188
JOD 0.738935
JPY 161.29026
KES 134.951747
KGS 90.142827
KHR 4221.417198
KMF 492.381009
KPW 937.860664
KRW 1463.470058
KWD 0.320801
KYD 0.869086
KZT 520.711055
LAK 22883.8102
LBP 93317.17572
LKR 303.520154
LRD 187.833126
LSL 18.872246
LTL 3.076956
LVL 0.630337
LYD 5.090542
MAD 10.435216
MDL 19.021591
MGA 4867.499257
MKD 61.527825
MMK 3384.595706
MNT 3540.946475
MOP 8.361391
MRU 41.594178
MUR 48.821273
MVR 16.100342
MWK 1809.030135
MXN 21.349193
MYR 4.655442
MZN 66.592021
NAD 18.872242
NGN 1768.080391
NIO 38.317227
NOK 11.54085
NPR 140.841219
NZD 1.787086
OMR 0.401188
PAB 1.042894
PEN 3.953646
PGK 4.19589
PHP 61.445013
PKR 289.490304
PLN 4.335151
PYG 8141.12374
QAR 3.793652
RON 4.97567
RSD 116.997165
RUB 107.700343
RWF 1428.675013
SAR 3.912282
SBD 8.721607
SCR 14.790679
SDG 626.807638
SEK 11.500881
SGD 1.404421
SHP 0.822522
SLE 23.676168
SLL 21851.646573
SOS 595.545589
SRD 36.987196
STD 21568.700427
SVC 9.125139
SYP 2618.22657
SZL 18.882654
THB 35.941305
TJS 11.106407
TMT 3.657658
TND 3.314301
TOP 2.440631
TRY 35.994243
TTD 7.082938
TWD 33.918306
TZS 2771.900812
UAH 43.142936
UGX 3853.318406
USD 1.042068
UYU 44.349277
UZS 13395.782472
VES 48.217013
VND 26499.785252
VUV 123.716388
WST 2.909027
XAF 656.708727
XAG 0.033301
XAU 0.000385
XCD 2.816241
XDR 0.793308
XOF 648.166544
XPF 119.331742
YER 260.416496
ZAR 18.903043
ZMK 9379.864807
ZMW 28.808701
ZWL 335.54542
  • CMSC

    0.0350

    24.675

    +0.14%

  • RBGPF

    -0.5000

    59.69

    -0.84%

  • GSK

    0.3150

    34.015

    +0.93%

  • NGG

    1.0696

    63.15

    +1.69%

  • RELX

    1.0600

    46.82

    +2.26%

  • BTI

    0.3700

    37.35

    +0.99%

  • BP

    0.1100

    29.63

    +0.37%

  • CMSD

    0.1350

    24.58

    +0.55%

  • RIO

    -0.2490

    62.321

    -0.4%

  • RYCEF

    0.0500

    6.84

    +0.73%

  • JRI

    0.0500

    13.28

    +0.38%

  • SCS

    0.2550

    13.295

    +1.92%

  • BCC

    3.6350

    143.995

    +2.52%

  • VOD

    0.1323

    8.73

    +1.52%

  • BCE

    0.1500

    26.83

    +0.56%

  • AZN

    1.4750

    65.735

    +2.24%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

(S.G.Stein--BBZ)